GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present additional data from both the NHS-Galleri trial and the PATHFINDER 2 study further ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

EDMONTON, AB, April 20, 2026 /CNW/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a peer-reviewed ...

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research ...

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...

A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...

A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...

While extracellular DNA persistence substantially influences soil microbiome investigations, its degradation kinetics remain poorly quantified. Here, we developed a primer-labeled DNA approach coupled ...